• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家庭血液透析患者的与操作相关的严重不良事件:质量保证视角。

Procedure-related serious adverse events among home hemodialysis patients: a quality assurance perspective.

机构信息

Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, Alberta.

Division of Nephrology, University of Ottawa, Ottawa, Ontario.

出版信息

Am J Kidney Dis. 2014 Feb;63(2):251-8. doi: 10.1053/j.ajkd.2013.07.009. Epub 2013 Aug 30.

DOI:10.1053/j.ajkd.2013.07.009
PMID:23993152
Abstract

BACKGROUND

There has been resurgent interest in home hemodialysis (HD) in recent years because of the reported benefits and its excellent safety record. However, the potential for adverse events, including potentially catastrophic ones, exists when patients are performing HD in their homes without supervision. There is a lack of literature on this important topic.

STUDY DESIGN

Quality improvement report.

SETTING & PARTICIPANTS: We present the experience of 2 adult home HD programs in Canada from 2001 to 2012, including a total of 190 patients and approximately 500 patient-years of treatments.

QUALITY IMPROVEMENT PLAN

We retrospectively reviewed all life-threatening adverse events occurring in our programs and re-examined our approach to patient training, retraining, and safety monitoring.

RESULTS

We report 1 death and 6 potentially fatal adverse events, yielding a crude rate of 0.060 events/1,000 dialysis treatments. Six of 7 events involved significant blood loss (including 1 exsanguination); 5 of 7 events involved human error with lapses in protocol adherence. Because such events are rare, evaluation of specific intervention strategies will require much longer follow-up.

LIMITATIONS

Retrospective identification of cases. A specific quality improvement initiative was not undertaken.

CONCLUSIONS

Life-threatening adverse events in home HD are uncommon; however, when one does occur, this should prompt review of home HD-related policies and procedures to make this therapy even safer.

摘要

背景

近年来,由于报告的益处及其出色的安全记录,家庭血液透析(HD)重新引起了人们的兴趣。然而,当患者在家中没有监督的情况下进行 HD 治疗时,存在发生不良事件的可能性,包括潜在的灾难性事件。关于这个重要主题的文献很少。

研究设计

质量改进报告。

地点和参与者

我们介绍了 2001 年至 2012 年加拿大 2 个成人家庭 HD 项目的经验,包括总共 190 名患者和大约 500 名患者的治疗。

质量改进计划

我们回顾性地审查了我们计划中发生的所有危及生命的不良事件,并重新审查了我们对患者培训、再培训和安全监测的方法。

结果

我们报告了 1 例死亡和 6 例潜在致命不良事件,粗发生率为 0.060 例/1000 次透析治疗。7 起事件中有 6 起涉及大量失血(包括 1 例失血性休克);7 起事件中有 5 起涉及违反协议的人为错误。由于此类事件很少见,评估特定干预策略将需要更长的随访时间。

局限性

病例的回顾性识别。没有进行特定的质量改进计划。

结论

家庭 HD 中的危及生命的不良事件并不常见;然而,当发生这种情况时,应该审查与家庭 HD 相关的政策和程序,以使这种治疗方法更加安全。

相似文献

1
Procedure-related serious adverse events among home hemodialysis patients: a quality assurance perspective.家庭血液透析患者的与操作相关的严重不良事件:质量保证视角。
Am J Kidney Dis. 2014 Feb;63(2):251-8. doi: 10.1053/j.ajkd.2013.07.009. Epub 2013 Aug 30.
2
Adverse technical events in home hemodialysis.家庭血液透析中的不良技术事件。
Am J Kidney Dis. 2015 Jan;65(1):116-21. doi: 10.1053/j.ajkd.2014.08.013. Epub 2014 Oct 16.
3
Patient safety in home hemodialysis: quality assurance and serious adverse events in the home setting.家庭血液透析中的患者安全:家庭环境中的质量保证与严重不良事件
Hemodial Int. 2015 Apr;19 Suppl 1:S59-70. doi: 10.1111/hdi.12248.
4
The umpire's call: safe at home, but the game is not over.裁判判罚:本垒安全,但比赛尚未结束。
Am J Kidney Dis. 2014 Feb;63(2):178-9. doi: 10.1053/j.ajkd.2013.11.007.
5
The evaluation of a successful home hemodialysis program: establishing a prospective framework for quality.成功的家庭血液透析项目评估:建立质量的前瞻性框架。
Clin Nephrol. 2009 May;71(5):467-74.
6
Experiences with establishing the first self-care hemodialysis program in a hospital in mainland China.在中国大陆的一家医院建立首个自我护理血液透析项目的经验。
Ren Fail. 2013;35(2):257-61. doi: 10.3109/0886022X.2012.747141. Epub 2012 Dec 11.
7
Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.长期透析治疗患者的死亡日变化:中心血液透析与腹膜和家庭血液透析的比较。
Am J Kidney Dis. 2013 Jan;61(1):96-103. doi: 10.1053/j.ajkd.2012.07.008. Epub 2012 Aug 16.
8
Lessons learned--one facility's experience with venturing into the home hemodialysis market.经验教训——一家机构进军家庭血液透析市场的经历。
Nephrol News Issues. 2006 Oct;20(11):70-1, 75.
9
Are adverse events in newly trained home dialysis patients related to learning styles? A single-centre retrospective study from Toronto, Canada.新培训的居家透析患者的不良事件与学习风格有关吗?来自加拿大多伦多的单中心回顾性研究。
BMJ Open. 2020 Jan 20;10(1):e033315. doi: 10.1136/bmjopen-2019-033315.
10
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.

引用本文的文献

1
An integrated alarm with clamp system to mitigate vascular access bleeding in hemodialysis: a prospective cohort mixed methods study.一种用于减轻血液透析中血管通路出血的带夹系统集成报警器:一项前瞻性队列混合方法研究。
BMC Nephrol. 2025 Jul 17;26(1):398. doi: 10.1186/s12882-025-04332-8.
2
Development and Investigation of a New Polysulfone Dialyzer with Increased Membrane Hydrophilicity.一种具有增强膜亲水性的新型聚砜透析器的研发与研究
Membranes (Basel). 2025 Apr 30;15(5):132. doi: 10.3390/membranes15050132.
3
Analysis of a nurse-provided on-call peritoneal dialysis support in an outpatient reference care centre.
门诊参考护理中心护士提供的随叫随到腹膜透析支持分析。
BMC Nurs. 2024 Mar 1;23(1):144. doi: 10.1186/s12912-024-01812-4.
4
From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities.从家庭到可穿戴血液透析:障碍、进展和机遇。
Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1488-1495. doi: 10.2215/CJN.0000000000000424. Epub 2024 Jan 8.
5
Patient Training and Patient Safety in Home Hemodialysis.家庭血液透析中的患者培训和患者安全。
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1045-1050. doi: 10.2215/CJN.0000000000000416. Epub 2024 Jan 8.
6
Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup.体外治疗乙二醇中毒:来自 EXTRIP 工作组的系统评价和建议。
Crit Care. 2023 Feb 10;27(1):56. doi: 10.1186/s13054-022-04227-2.
7
Risk assessment of failure during transitioning from in-centre to home haemodialysis.中心向居家血液透析转换过程中失败风险评估。
BMC Nephrol. 2022 Dec 20;23(1):406. doi: 10.1186/s12882-022-03039-4.
8
Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.体外治疗甲氨蝶呤中毒:EXTRIP 工作组的系统评价和建议。
Clin J Am Soc Nephrol. 2022 Apr;17(4):602-622. doi: 10.2215/CJN.08030621. Epub 2022 Mar 2.
9
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒:EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
10
Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.体外治疗氯喹、羟氯喹和奎宁中毒:来自 EXTRIP 工作组的系统评价和建议。
J Am Soc Nephrol. 2020 Oct;31(10):2475-2489. doi: 10.1681/ASN.2020050564. Epub 2020 Sep 22.